Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Enanta Pharmaceuticals"
Count: 34
Selected: 0
NCT IDTitle
NCT04470388A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment
NCT04008004A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)
NCT04498741Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects
NCT04633187Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Who Are Infected With Acute Respiratory Syncytial Virus (RSV) of the Upper Respiratory Tract
NCT04816721A Study to Evaluate EDP 938 Regimens in Children With RSV
NCT03691623A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model
NCT03394924A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis
NCT04927793Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male Subjects
NCT05246878A Study of EDP-235 in Healthy Subjects
NCT04971512A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.
NCT04196101A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects
NCT04559126A Study of EDP-297 in Healthy Subjects
NCT03421431A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
NCT04783753Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects
NCT04378010A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH
NCT04871724Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy Subjects
NCT03755778Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects
NCT03750383Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects
NCT03384823A Study of EDP-938 in Healthy Subjects
NCT03783897A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects
NCT03610945Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers
NCT03748628Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects
NCT02918929A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD
NCT03213145Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers
NCT03207425A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers
NCT03187496Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers.
NCT02652377EDP-494-001: A Study of EDP-494 in Healthy Subjects and Hepatitis C Patients
NCT01856426Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects
NCT02255968Evaluation of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of EDP-788
NCT02173574Two-way Interaction Between Alisporivir and EDP239
NCT01999725Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788
NCT00990145Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers
NCT00989872Safety and Pharmacokinetics of Ascending Single Oral Doses of EDP-322 in Nonfasting and Fasting Healthy Volunteers
NCT00270517Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia